Clinical Trials Directory

Trials / Completed

CompletedNCT03326609

Local Anesthetic Concentration and Nerve Block Duration

Local Anesthetic Concentration and Nerve Block Duration: A Randomized, Blinded Study in Healthy Volunteers

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Nordsjaellands Hospital · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

Background: Local anesthetic (LA) concentration and nerve block duration is sparsely described in a heterogenic study mass. Aim: To investigate the effect of LA concentration on peripheral nerve block duration in healthy volunteers. Methods: Randomization of 60 healthy volunteers who will receive 1 of 5 different volumes of LA (ropivacaine) using a constant dose. Primary endpoint: Sensory nerve block defined by insensitivity towards cold.

Detailed description

Background: Important factors for a safe and successful nerve block include volume, dose and concentration of local anesthetic (LA). Knowing the duration of peripheral nerve blocks is important to prevent pain breakthrough. With the advancements in ultrasound (US)-guided nerve block techniques it has been possible to substantially reduce the amount of LA required to perform a successful nerve block. This has reduced the risk of systemic toxicity. However, lowering LA volume may reduce nerve block duration, but the extent of this is sparsely described in a heterogenic study mass. Diluted and large volumes of LA seem to correlate with nerve block duration. Furthermore, increasing LA concentration seems to increase the level of motor block, but not the block duration. A long-lasting nerve block without dense motor block is preferable for optimized pain control and better opportunities to rehabilitate/ambulate. Aim: To investigate the effect of LA concentration on common peroneal nerve block duration in healthy volunteers. Methods: Randomization of 60 healthy volunteers who will receive 1 of 5 different volumes of LA (ropivacaine) using a constant dose (10mg). Primary outcome: Duration of sensory nerve block defined by insensitivity towards cold. Secondary outcome: Duration of motor nerve block defined by either paresis or paralysis. Explorative outcomes: Degrees of sensory and motor nerve block; Onset times of sensory and motor nerve block; Length of neural exposure to LA.

Conditions

Interventions

TypeNameDescription
DRUGRopivacainePerineural injection using a peripheral nerve block catheter and a constant infusion rate (10mL/h)

Timeline

Start date
2017-10-04
Primary completion
2017-12-08
Completion
2018-01-05
First posted
2017-10-31
Last updated
2018-01-08

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03326609. Inclusion in this directory is not an endorsement.